Transcript for Earnings call- Q4- FY 2025-26

CAPLIPOINT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.7%1-day move

₹2027.00

prior close

₹2025.90

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.3+0.0+0.2+2.7+0.9-0.1-0.7-1.3-3.1+17.1+24.8+22.6—

Up moveDown movePending

AI summary

Caplin Point Laboratories Ltd submitted a regulatory intimation to BSE and NSE on May 21, 2026, confirming the availability of the transcript for its Q4 FY 2025-26 earnings call held on May 14, 2026. The filing references a prior letter dated May 07, 2026 and is made pursuant to SEBI Regulation 30(6) of the LODR Regulations, 2015. The transcript itself is hosted externally on the company's website. The filing is a standard procedural disclosure and does not contain any substantive financial figures, guidance, or commentary within the body of the intimation itself.

Likely market impact

This is a routine compliance filing confirming that the Q4 earnings call transcript is publicly accessible; it does not itself move the stock or contain new financial information.